Alzheimer Disease Clinical Trials in Shanghai
3 recruitingShanghai, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
Alzheimer DiseasePositron Emission Tomography
Huashan Hospital3,000 enrolled1 locationNCT06827678
Recruiting
Not Applicable
Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers
Cognitive ImpairmentAlzheimer Disease
ZhanYJ176 enrolled1 locationNCT06417086